This company has shut down. Frequency Therapeutics is no longer operating.
Explore the Startup GraveyardFrequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Frequency Therapeutics's investors include RTW Investments, Perceptive Advisors, Breakthrough T1D, Taiwania Capital Management Corporation, Alexandria Venture Investments.
Frequency Therapeutics is headquartered in Lexington, United States.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Frequency Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Frequency Therapeutics — Funding & Investors." VCBacked, August 15, 2022, https://www.vcbacked.co/company/frequency-therapeutics. Accessed November 15, 2026.
VCBacked. (2022). Frequency Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/frequency-therapeutics
{{cite web |title=Frequency Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/frequency-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Frequency Therapeutics? Request a listing update